医药市场外包服务提供商PCI Pharma Services完成对Ajinomoto Althea的收购，以扩大预填充注射器和药筒的无菌灌装能力-动脉网

PCI Pharma Services Completes Acquisition of Ajinomoto Althea to Expand Aseptic Filling for Prefilled Syringes and Cartridges

GeneOnline 等信源发布 2025-08-28 20:06



可切换为仅中文







by Mark Chiang

马克·蒋

Share To

分享至

PCI Pharma Services has finalized its acquisition of Ajinomoto Althea, a move aimed at strengthening its drug product manufacturing capabilities in the United States. The acquisition is part of PCI’s broader $1 billion investment strategy and focuses on expanding aseptic filling services for prefilled syringes and cartridges..

PCI制药服务公司已完成对味之素Althea的收购，此举旨在加强其在美国的药物产品制造能力。此次收购是PCI更广泛的10亿美元投资战略的一部分，重点是扩大预填充注射器和药筒的无菌灌装服务。

The completion of this deal marks a significant step in PCI Pharma Services’ efforts to enhance its manufacturing infrastructure. By integrating Ajinomoto Althea’s expertise, PCI aims to bolster its capacity for producing sterile injectable products, which are critical components in pharmaceutical delivery systems.

这笔交易的完成标志着PCI制药服务公司在加强其生产基础设施方面迈出了重要一步。通过整合味之素Althea的专业知识，PCI旨在增强其生产无菌注射产品的能力，这些产品是药物递送系统中的关键组成部分。

This development aligns with the company’s long-term strategy to meet growing demand for advanced drug delivery solutions while maintaining high standards of quality and efficiency..

这一发展符合公司满足先进药物输送解决方案日益增长的需求，同时保持高质量和高效率标准的长期战略。

Newsflash | Powered by GeneOnline AI

新闻快讯 | 由GeneOnline AI提供支持

Source: GO-AI-ne1

来源：GO-AI-ne1

Date: August 28, 2025

日期：2025年8月28日

Study Links Cigars, Pipes, and Smokeless Tobacco to Increased Heart Disease Risk

研究发现雪茄、烟斗和无烟烟草会增加心脏病风险

DrugPatentWatch.com: Partnering with CDMOs May Expedite Pharmaceutical Time-to-Market.

DrugPatentWatch.com：与CDMO合作可能加速药品上市时间。

Study Reveals Ventral Tegmental Area Encodes Timing of Anticipated Rewards Alongside Reward Prediction